Cargando…
Interim analysis from a phase 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccine
BACKGROUND: Numerous vaccine strategies are being advanced to control SARS-CoV-2, the cause of the COVID-19 pandemic. EuCorVac-19 (ECV19) is a recombinant protein nanoparticle vaccine that displays the SARS-CoV-2 receptor-binding domain (RBD) on immunogenic nanoliposomes. METHODS: Initial study of a...
Autores principales: | Lovell, Jonathan F., Baik, Yeong Ok, Choi, Seuk Keun, Lee, Chankyu, Lee, Jeong-Yoon, Miura, Kazutoyo, Huang, Wei-Chiao, Park, Young-Shin, Woo, Sun-Je, Seo, Sang Hwan, Kim, Jae-Ouk, Song, Manki, Kim, Chung-Jong, Choi, Jae-Ki, Kim, Jieun, Choo, Eun Ju, Choi, Jung-Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708508/ https://www.ncbi.nlm.nih.gov/pubmed/36447243 http://dx.doi.org/10.1186/s12916-022-02661-1 |
Ejemplares similares
-
Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, Euvichol, in an animal model
por: Lee, Eun Young, et al.
Publicado: (2018) -
Are titanium implants actually safe for magnetic resonance imaging examinations?
por: Kim, Yong-Ha, et al.
Publicado: (2019) -
Reduction of free polysaccharide contamination in the production of a 15-valent pneumococcal conjugate vaccine
por: Whang, Yoon Hee, et al.
Publicado: (2020) -
Folate-Targeted Nanoliposomal Chemophototherapy
por: Chitgupi, Upendra, et al.
Publicado: (2023) -
Cytotoxic Effects of Nanoliposomal Cisplatin and Diallyl Disulfide on Breast Cancer and Lung Cancer Cell Lines
por: Gunasekaran, Kaavya, et al.
Publicado: (2023)